特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
935428

非ホジキンリンパ腫治療薬の世界市場 - 業界分析、規模、シェア、成長率、動向、予測:2019年~2026年

Global Non-Hodgkin Lymphoma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

出版日: | 発行: Value Market Research | ページ情報: 英文 95 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
非ホジキンリンパ腫治療薬の世界市場 - 業界分析、規模、シェア、成長率、動向、予測:2019年~2026年
出版日: 2020年05月01日
発行: Value Market Research
ページ情報: 英文 95 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の非ホジキンリンパ腫治療薬市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています

目次

第1章 : 序文

  • レポートについて
  • 調査範囲
  • 調査手法

第2章 : エグゼクティブサマリー

  • 市場のハイライト
  • 市場のスナップショット

第3章 : 業界分析

  • イントロダクション
  • 市場成長要因
  • 市場抑制要因
  • 市場の機会
  • 市場の動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 :バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
  • 潜在的なバイヤーリスト
  • マーケティングチャネル

第5章 :世界の非ホジキンリンパ腫治療薬市場分析 癌の種類別

  • 概要
  • 市場分析
  • 神経膠腫の市場分析
  • 髄膜腫の市場分析
  • 下垂体腺腫の市場分析
  • シュワン腫の市場分析
  • 髄芽腫の市場分析

第6章 :世界の非ホジキンリンパ腫治療薬市場分析 治療別

  • 概要
  • 市場分析
  • 放射線療法の市場分析
  • 化学療法の市場分析
  • 子標的治療の市場分析

第7章 :世界の非ホジキンリンパ腫治療薬市場分析 地域別

  • 地域の見通し
  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 :企業競合情勢

  • 市場の競合
  • パートナーシップ/コラボレーション/契約
  • 合併と買収
  • 新製品の発売
  • その他

第9章 :業企業プロファイル

  • 会社シェア分析
  • 市場集中率
  • Bayer AG
  • Bristol Myers Squibb Co.
  • F. Hoffman La-Roche Ltd.
  • GlaxoSmithKline plc
  • Merck
  • Novartis
  • Pfizer
  • その他

10. COVID_19パンデミックの影響分析

  • 市場でのCOVID_19パンデミックの影響分析
    • 生産への直接的な影響
    • サプライチェーンと市場の混乱
    • 企業と金融市場への財政的影響
  • COVID-19生産、輸入、輸出および需要別影響分析
  • プレ、ポストCOVID-19市場
  • シナリオ別、2020年の市場規模に対するコロナウイルス(COVID-19)の影響の推定
  • COVID-19:市場のマイクロおよびマクロ因子分析
図表

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Glioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Meningioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Pituitary Adenoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Schwannomas by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Medulloblastoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Therapeutics (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Radiation Therapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Chemotherapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Targeted Therapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market by Geography (USD MN)
  • North America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • United State Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • United State Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of North America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Europe Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • United Kingdom Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • United Kingdom Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • France Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • France Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Germany Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Germany Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • China Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • China Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Japan Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Japan Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • India Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • India Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • Brazil Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Brazil Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • Middle East Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Middle East Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Africa Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of Non-Hodgkin Lymphoma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Non-Hodgkin Lymphoma Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Therapeutics
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Glioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Meningioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Pituitary Adenoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Schwannomas by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Medulloblastoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Therapeutics (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Radiation Therapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Chemotherapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Targeted Therapy by Geography (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market by Revenue
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market by Revenue
  • Recent Development in Non-Hodgkin Lymphoma Therapeutics Industry
  • Company Market Share Analysis, 2019
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次

Value Market Research's latest report on the Global Non-Hodgkin Lymphoma Therapeutics Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global non-hodgkin lymphoma therapeutics market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global non-hodgkin lymphoma therapeutics market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global non-hodgkin lymphoma therapeutics market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global non-hodgkin lymphoma therapeutics market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global non-hodgkin lymphoma therapeutics market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global non-hodgkin lymphoma therapeutics market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global non-hodgkin lymphoma therapeutics market.

The market analysis involves a section exclusively to list the major players of the global non-hodgkin lymphoma therapeutics market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Non-Hodgkin Lymphoma Therapeutics Market Report Segments the market as below -

By Cancer Type

Glioma

Meningioma

Pituitary Adenoma

Schwannomas

Medulloblastoma

By Therapeutics

Radiation Therapy

Chemotherapy

Targeted Therapy

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Non-Hodgkin Lymphoma Therapeutics Market
  • 2.2. Global Non-Hodgkin Lymphoma Therapeutics Market Snapshot

3 . NON-HODGKIN LYMPHOMA THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.3. Market Restraints of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.4. Opportunities of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.5. Trends of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.6. Porter's Five Force Analysis of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.7. Non-Hodgkin Lymphoma Therapeutics Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Cancer Type
    • 3.7.2 Market Attractive Analysis by Therapeutics
    • 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Non-Hodgkin Lymphoma Therapeutics Value Chain Analysis
  • 4.2. Non-Hodgkin Lymphoma Therapeutics Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Non-Hodgkin Lymphoma Therapeutics Raw Material Manufactures List
    • 4.2.3. Price Trend of Non-Hodgkin Lymphoma Therapeutics Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY CANCER TYPE

  • 5.1 Overview by Cancer Type
  • 5.2 Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type
  • 5.3 Market Analysis of Glioma by Regions
  • 5.4 Market Analysis of Meningioma by Regions
  • 5.5 Market Analysis of Pituitary Adenoma by Regions
  • 5.6 Market Analysis of Schwannomas by Regions
  • 5.7 Market Analysis of Medulloblastoma by Regions

6 . GLOBAL NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS

  • 6.1 Overview by Therapeutics
  • 6.2 Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Therapeutics
  • 6.3 Market Analysis of Radiation Therapy by Regions
  • 6.4 Market Analysis of Chemotherapy by Regions
  • 6.5 Market Analysis of Targeted Therapy by Regions

7 . GLOBAL NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview
    • 7.3.2. North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.3.3. North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.3.4. United State
    • 7.3.5. Rest of North America
  • 7.4. Europe
    • 7.4.1. Overview
    • 7.4.2. Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.4.3. Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7 Rest of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview
    • 7.5.2. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.5.3. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.5.4. China
    • 7.5.5. Japan
    • 7.5.6. India
    • 7.5.7. Rest of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview
    • 7.6.2. Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.6.3. Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.6.4. Brazil
    • 7.6.5. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview
    • 7.7.2. Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.7.3. Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.7.4. Middle East
    • 7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE NON-HODGKIN LYMPHOMA THERAPEUTICS COMPANIES

  • 8.1. Non-Hodgkin Lymphoma Therapeutics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF NON-HODGKIN LYMPHOMA THERAPEUTICS INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Bayer AG
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Bristol Myers Squibb Co.
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. F. Hoffman La-Roche Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. GlaxoSmithKline plc
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Merck
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Novartis
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Pfizer
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Others
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 10.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 10.1.1. Direct Impact on Production
    • 10.1.2. Supply Chain and Market Disruption
    • 10.1.3. Financial Impact on Firms and Financial Markets
  • 10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 10.3. Pre V/S Post COVID-19 Market
  • 10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 10.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note: in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies.

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.